Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration is a research paper published in Mediators of Inflammation (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Veterans Affairs
Grant: VA-I01-BX005845
Veterans Affairs
Grant: IK6BX004016
Veterans Affairs
Grant: R01 DK130243
Veterans Affairs
Grant: 1R21 AA029747-02
NHLBI NIH HHS
Grant: R01 HL170056
BLRD VA
Grant: I01 BX005845
NIAAA NIH HHS
Grant: R21 AA029747
National Institutes of Health
Grant: 5IK6BX004016-05
BLR&D Research Career Scientist Award Application
National Institutes of Health
Grant: 5I01BX005845-04
RECK in Adverse Cardiac Remodeling and Heart Failure
National Institutes of Health
Grant: 5R21AA029747-02
Role of novel RNA binding protein LARP6 in alcoholic cardiomyopathy
National Institutes of Health
Grant: 5R01DK130243-04
RECK regulation of NASH and fibrosis
FWCI
0.90
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords